Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has introduced that it has reached an settlement with the Lawyer Basic of Florida that settles the state’s opioid-related claims.
Underneath the phrases of the settlement, Teva can pay Florida $177 million over 15 years. The Israeli pharmaceutical firm may also present Florida its not too long ago launched generic opioid overdose therapy Narcan (naloxone hydrochloride nasal spray) valued at $84 million (wholesale acquisition price) over 10 years.
RELATED ARTICLES
Teva mentioned that the settlement is one other vital step ahead in getting life-saving therapies to individuals affected by opioid dependancy and burdened that the settlement settlement shouldn’t be an admission of any legal responsibility or wrongdoing. Teva mentioned that it will proceed to defend itself in courtroom in states the place it has not reached phrases of a settlement settlement.
In February, Teva reached an identical settlement with Texas, wherein it is going to pay $150 million over 15 years and supply Narcan price $75 million (wholesale acquisition price) over 10 years. Final week Teva reached a settlement with Rhode Island wherein it is going to pay $21 million over 13 years and $78.5 million in Narcan and different therapies over 10 years.
Revealed by Globes, Israel enterprise information – en.globes.co.il – on March 30, 2022.
© Copyright of Globes Writer Itonut (1983) Ltd., 2022.
